Results 201 to 210 of about 12,781,003 (329)
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Multivariate Characterization of Essential Oils for Their Antibacterial Activity Against <i>Escherichia coli</i>: A Data-Driven Interpretation of Experimental Results. [PDF]
Kokalj Ladan M, Supé Vide M, Schoss K.
europepmc +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
β-Cyclodextrin Inclusion Complexes of <i>Cinnamomum camphora</i> Essential Oil: A Comparative Study on Encapsulation Strategies, Physicochemical Stability, and Cytotoxic Profile. [PDF]
Nascimento Júnior JAC +11 more
europepmc +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
Lower Toxicity of the Essential Oils With Repellent Potential Compared to Diethyltoluamide and Cypermethrin on <i>Porcellio laevis</i>. [PDF]
Silva-Díaz H +3 more
europepmc +1 more source

